Latest Conference Articles

Jeffrey Gudin, MD, outlines the steps pharmacists should take to reduce opioid-induced constipation.

Mary M. Bridgeman, PharmD, BCPS, CGP, discusses the latest advancements in OIC treatment.

Juliana Zschoche, PharmD, emergency medicine clinical pharmacy specialist at Johns Hopkins Hospital, discusses potential adverse effects associated with naloxone.

Mary M. Bridgeman, PharmD, BCPS, CGP, discusses how pharmacy-based OIC care differs from other settings.

Juliana Zschoche, PharmD, emergency medicine clinical pharmacy specialist at Johns Hopkins Hospital, discusses how health-system pharmacists can assess patients' risk for opioid overdose.

Mary M. Bridgeman, PharmD, BCPS, CGP, discusses OTC recommendations for OIC symptoms.

Mary M. Bridgeman, PharmD, BCPS, CGP, discusses how often pharmacists work with OIC patients.

Juliana Zschoche, PharmD, emergency medicine clinical pharmacy specialist at Johns Hopkins Hospital, discusses what pharmacists should tell patients about administering naloxone.

Juliana Zschoche, PharmD, emergency medicine clinical pharmacy specialist at Johns Hopkins Hospital, discusses key stakeholders involved in developing and implementing outpatient naloxone policies.

Juliana Zschoche, PharmD, emergency medicine clinical pharmacy specialist at Johns Hopkins Hospital, discusses how health-system and community pharmacists can work together to provide naloxone.

Juliana Zschoche, PharmD, emergency medicine clinical pharmacy specialist at Johns Hopkins Hospital, discusses prices of naloxone products.

Jeffrey Gudin, MD, describes the impact of opioid-induced constipation on patients taking opioids.

Mary M. Bridgeman, PharmD, BCPS, CGP, discusses where fiber supplementation fits into OIC care.

There are many misconceptions surrounding pain management, especially when it comes to opioids with abuse-deterrent properties.

J. David Haddox, DDS, MD, describes how clinicians can determine whether an opioid has abuse-deterrent properties.

J. David Haddox, DDS, MD, describes the pharmacist's role in deterring opioid abuse.

The answer may surprise you.

J. David Haddox, DDS, MD, describes the most common method of opioid abuse.

J. David Haddox, DDS, MD, corrects a misconception about opioids with abuse-deterrent properties.

J. David Haddox, DDS, MD, explains how most nonmedical opioid users obtain the drug.

Christopher Betz, PharmD, BCPS, FKSHP, FASHP, explains how the updated ACC/AHA guidelines on acute coronary syndrome might affect pharmacy practice.

Christopher Betz, PharmD, BCPS, FKSHP, FASHP, explains how motivational interviewing techniques may help to promote medication adherence among ACS patients.

Christopher Betz, PharmD, BCPS, FKSHP, FASHP, discusses the investigations that preceded the ACC/AHA Updated Heart Failure Guidelines

Christopher Betz, PharmD, BCPS, FKSHP, FASHP, describes how pharmacists can help ACS patients who struggle with low health literacy.

Seena Haines, PharmD, BCACP, FAPhA, BC-ADM, outlines how pharmacists can optimize their role in creating hospital discharge plans for diabetes patients.

Seena Haines, PharmD, BCACP, FAPhA, FASHP, BC-ADM, CDE, lists out factors that may contribute to the likelihood of a patient with diabetes needing to be readmitted.

Seena Haines, PharmD, BCACP, FAPhA, BC-ADM, discusses the types of goals pharmacists should discuss with patients with diabetes in order to avoid readmissions.

The Institute for Safe Medication Practices recently added new best practices for improving patient safety in hospitals.

Health-system pharmacists play a vital role in treating patients with HIV from the time they're admitted to their potential readmission, as well as through follow up after discharge.

An alarming 15% of patients who enter the hospital without any pain medications fill opioid prescriptions soon after discharge.